MYC and ovarian serous adenocarcinoma: To further validate the relevance of MYC, EGFR, and CCND1 to platinum chemotherapy response, we analyzed their differential expression between platinum-sensitive and platinum-resistant high-grade serous ovarian cancer cells based on GEO microarray (GSE189717).